REFERENCES
- Abu-Ghoush MW. Subtypes of α thalassemia diagnosed at a medical center in Jordan. TAF Preventive Med Bull. 2008;7(5):373–376.
- Schrier SL, Bunyaratvej A, Khuhapinant A, The unusual pathobiology of Hemoglobin Constant Spring red blood cells. Blood. 1997;89(5):1762–1769.
- Adekile AD, Yüregir TZ, Walker EL, Gu L-H, Baysal E, Huisman THJ. Factors associated with hypochromia and microcytosis among high school students in the southeastern United States. South Med J. 1994;87(11):1132–1137.
- Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol. 2003;74(2):99–103.
- Neishabury M, Oberkanins C, Moheb LA, High prevalence of the –α3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003;27(1):53–55.
- Garshasbi M, Oberkanins C, Law HY, Neishabury M, Kariminejad R, Najmabadi H. α-Globin gene deletion and point mutation analysis among Iranian patients with microcytic hypochromic anemia. Haematologica. 2003;88(10):1196–1197.
- Hadavi V, Jafroodi M, Hafezi-Nejad N, α-Thalassemia mutations in Gilan Province, North Iran. Hemoglobin. 2009;33(3-4):1–7.
- Tamaddoni A, Hadavi V, Hafezi-Nejad N, α-Thalassemia mutation analysis in Mazandaran, Iran. Hemoglobin. 2009;33(2):115–123.
- Zandian Kh, Nateghi J, Keikhaie B, α-Thalassemia mutations in Khuzestan, Iran. Hemoglobin. 2008;32(6):546–552.
- Hadavi V, Taromchi AH, Malekpour M, Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993.
- Galanello R, Aru B, Dessì C, Hb H disease in Sardinia: molecular, hematological and clinical aspects. Acta Haematol. 1992;88(1):1–6.
- Weatherall DJ. Phenotype-genotype relations in monogenic diseases; lesson from the thalassaemias. Nat Genet. 2001;2(4):245–255.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988;16(3):1215.
- Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994;46(3):208–213.
- Puehringer H, Najmabadi H, Law HY, Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions. Clin Chem Lab Med. 2007;45(5):605–610.
- Najmabadi H, Ghamari A, Sahebjam F, Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006;9(2):93–97.
- Lau YL, Chan LC, Chan YY, Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong–implications for population screening. N Engl J Med. 1997;336(18):1298–1301.
- Deny S, Wood WG, Pippard M, Hematologic and biosynthetic studies in homozygous Hemoglobin Constant Spring. J Clin Invest. 1984;73(6):1673.
- Winichagoon P, Higgs DR, Goodbourn SE, Clegg JB, Weatherall DJ, Wasi P. The molecular basis of α-thalassaemia in Thailand. EMBO J. 1984;3(8):1813–1818.
- Lorey F, Cunningham G, Vichinsky EP. Universal newborn screening for Hb H disease in California. Genet Test. 2001;5(2):93–100.